A
ADMA Biologics D
D
ADMA
16.480
USD
0.30
(1.85%)
مغلق
حجم التداول
107,789
الربح لكل سهم
1
العائد الربحي
-
P/E
61
حجم السوق
3,895,711,369
المقالات
العنوان: ADMA Biologics
القطاع: Healthcare
الصناعة: Biotechnology
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and othersat risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions tocertain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.